ESBL E. coli Urosepsis Resulting in Endogenous Panophthalmitis Requiring Evisceration of the Eye in a Diabetic Patient

Case Reports in Infectious Diseases
Tejaswini Arunachala MurthyKarthik Rao

Abstract

A primary infection in a remote site resulting in vision threatening complications like panophthalmitis in a person who is not immune-compromised is rare. We report a case of endogenous bilateral bacterial endophthalmitis progressing into panophthalmitis in one eye requiring evisceration of that eye. A patient admitted with severe ESBL E. coli urosepsis was effectively treated with source control (bilateral DJ stenting for hydroureteronephrosis) and antibiotics. She was found to have features suggestive of bilateral conjunctivitis which progressed to panophthalmitis possibly due to delay in appropriate diagnosis and treatment. Diagnosis requires a very high index of suspicion if eye involvement is noted in a patient with features of bacteraemia and early intervention could possibly produce better outcomes. To our knowledge, this is the first case of ESBL E. coli urosepsis complicated by microbiologically confirmed panophthalmitis.

References

Oct 11, 1992·Archives of Ophthalmology·W D IrvineS C Pflugfelder
Dec 23, 1998·Survey of Ophthalmology·M S KresloffM A Zarbin
Jan 10, 2002·Clinical Microbiology Reviews·Michelle C CalleganMichael S Gilmore
Mar 12, 2002·Clinical & Experimental Ophthalmology·Tanuj DadaRasik B Vajpayee
Jul 10, 2003·Survey of Ophthalmology·Timothy L JacksonMiles R Stanford
Apr 3, 2004·American Journal of Ophthalmology·Vivian SchiedlerDarlene Miller
Nov 9, 2006·Indian Journal of Medical Sciences·Tulsi KeswaniManish Changulani
Jun 6, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Y KeynanP Lagacé-Wiens
Feb 27, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M L Durand
Mar 22, 2013·Journal of Ophthalmic Inflammation and Infection·Animesh JindalHarry W Flynn
Aug 13, 2014·Survey of Ophthalmology·Timothy L JacksonIlias Georgalas

❮ Previous
Next ❯

Citations

Nov 1, 2016·Japanese Journal of Infectious Diseases·Simranjeet AulakhChhaya A Shinde

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.